Akiyama K, Sutoo D. The relationship
betweenstress and epilepsy. Eur J Pharmacol
; 183:227
Arib O, Rat P, Molimard R, Chait A, Faure P, de
Beaurepaire R. Electrophysiological
characterization of harmane-induced activation
of mesolimbic dopamine neurons. Eur J
Pharmacol 2010; 629(1-3): 47-52-
Bueno CH, Zangrossi H, Jr., Viana MB. The
inactivation of the basolateral nucleus of the rat
amygdala has an anxiolytic effect in the
elevated T-mazeand light/dark transition tests.
Braz J Med Biol Res 2005; 38: 1697-1701.
Cortese BM, Phan KL. The role of glutamate
inanxiety and related disorders. CNS Spectr
; 10(10):820-30.
Davis M, Shi C. The extended amygdala: are
thecentral nucleus of the amygdala and the
bednucleus of the stria terminalis differentially
involved in fear versus anxiety? Ann N Y Acad
Sci 1999; 877: 281-91
File SE, Kenny PJ, Cheeta S. The role of the
dorsal hippocampal serotonergic and
cholinergic systems in the modulation of
anxiety. Pharmacology, biochemistry, and
behavior 2000; 66: 65-72
Freedland CS, Mansbach RS. Behavioral profile
of constituents in ayahuasca, an Amazonian
psychoactive plant mixture. Drug Alcohol
Depend 1999; 54:183-94
Fuentes JA,Longo VG.Aninvestigation on the
central effects of harmine,harmaline and related
beta-Carbolines.Neuropharmacology.1971.10(
:15-23.
Glennon RA, Dukat M, Grella B, Hong S,
Costantino L Teitler M, et al. Binding of betacarbolines
and related agents at serotonin (5-HT
(2) and 5-HT(1A)), dopamine (D(2)) and
benzodiazepine
receptors. Drug Alcohol Depend 2000; 60:
-32.
Gonzalez LE, Andrews N, File SE. 5-HT1A
and benzodiazepine receptors in the basolateral
amygdala modulate anxiety in the social
interaction test, but not in the elevated plusmaze.
Brain Res1996; 732: 145-153.
Herraiz T, Chaparro C. Human monoamine
oxidase is inhibited by tobacco smoke: betacarboline
alkaloids act as potent and reversible
inhibitors. Biochem Biophys Res Commun
14; 326:378-86.
Hillberp C,Hapillon P, Effect of harmaline on
anxiety related behavior in mice.Physiol Behav
(2005) :164-167
Janhunen S, Ahtee L. Differential nicotinic
regulation of the nigrostriatal and mesolimbic
dopaminergic pathways: implications for drug
development. Neurosci Biobehav Rev 2007; 31:
-314.
Le Doux J. The emotional brain, fear, and the
amygdala. Cell Mol Neurobiol 2003; 23:727-
Liebsch G, Landgraf R, Gerstberger R, et al.
Chronic infusion of a CRH receptor
antisenseoligodeoxynucleotide into the central
nucleus of the amygdala reduced anxietyrelated
behavior insocially defeated rats.
Regulatory peptides, 1995; 59: 229-239.
Masse F, Hascoet M, Dailly E, Bourin M.
Effectof noradrenergic system on the
anxiolytic-like effectof DOI (5-HT2A/2C
agonists) in the four-plate
test.Psychopharmacology (Berl) 2006;
(4):471-81.
Pandaranandaka J, Poonyachoti S,
Kalandakanond-Thongsong S. Anxiolytic
property of estrogen related to the changes of
the monoamine levels in various brain regions
of ovariectomizedrats. Physiol Behav 2006;
(4):828-35.
Pellow S. File SE. Anxiolytic and
AnxiogenicDrug Effects on Exploratory
Activity in an Elevated Plus-Maze: a Novel
Test of Anxiety in the Rat.Pharmacol. Biochem
Behav 986;24:525-529.
Pfau W, Skog K. Exposure to beta-carbolines
norharman and harman. J Chromatogr B
AnalytTechnol Biomed Life Sci 2004; 802:115-
Picentini MP,Piatti E,franternale D,Ricci
D,Assorsi A.Phospholipase C-dependent
phosphor-inositide break down induced by EIFEMP
in peganum harmala call.Biochem
;86( 5):343-9
Poorthuis RB, Goriounova NA, Couey JJ,
Mansvelder HD. Nicotinic actions on
neuronalnetworks for cognition: general
principles and long-term consequences.
Biochem Pharmacol 2009;78: 668-76.
Rezayat M, Roohbakhsh A, Zarrindast MR,
Massoudi R,Djahanguiri B. Cholecystokinin
and GABA interaction in the dorsal
hippocampus of rats in the elevated plus-maze
test of anxiety.
Physiology and behavior 2005; 84: 775-782.
Sharaf EL, Ansari MA, Martin four flavonoide
glycosidesfrom peganum harmala
Phytochemistry 44(1997) 533-536.
Spijkerman R, van den Eijnden R, van de
Mheen D, Bongers I, Fekkes D. The impact of
smoking and drinking on plasma levels of
norharman. Eur Neuropsychopharmacol 2002;
(1): 61-71
Squires PE, Hills CE, Rogers GJ, Garland P,
Farley SR, Morgan NG.The putative
imidazoline receptor agonist, harmane,
promotes intracellular calcium mobilisation in
pancreatic beta-cells. Eur
J Pharmacol 2004; 501: 31-9.
Walker DL, Toufexis DJ, Davis M. Rote ofthe
Bed Nucleus of the Stria Terminalis Versus the
Amygdala in Fear, Stress and Anxiety. Eur
JPharmacol 2003; 463:199-216.
Zarrindast MR, Homayoun H, Babaie A,
Etminani A, Gharib B. Involvement of
adrenergic and cholinergic systems in nicotineinduced
anxiogenesis in mice. Eur J Pharmacol
; 407: 145-15
Zarrindast M, Solati J, Oryan S, Parivar K.
Effect of Intra-Amygdala Injection of Nicotine
and GABA Receptor Agents on Anxiety-Like
Behavior in Rats. Pharmacology 2008; 82: 276-
Zarrindast MR, Torabi M, Rostami P, Fazli-
Tabaei S. The effects of histaminergic agents in
the dorsal hippocampus of rats in the elevated
plus-maze test of anxiety. Pharmacology,
biochemistry, and behavior 2006; 85: 500-506.
Pidoplichko VI, Noguchi J, Areola OO, Liang
Y, Peterson J, Zhang T, et al. Nicotine
cholinergic Synaptic mechanisms in the ventral
tegmental area contribute to nicotine
addiction.Learn Mem,2004;11( 1):60-9
)